Current Report Filing (8-k)
November 06 2019 - 8:20AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): November 6, 2019
Blonder
Tongue Laboratories, Inc.
(Exact Name of registrant as specified
in its charter)
Delaware
|
|
1-14120
|
|
52-1611421
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
One Jake Brown Road, Old Bridge, New
Jersey 08857
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number,
including area code: (732) 679-4000
Not Applicable
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
☐
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading symbol(s)
|
|
Name of each exchange on which registered
|
Common Stock, par value $.001
|
|
BDR
|
|
NYSE American
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
2.02 Results of Operations and Financial Condition
On November 6, 2019, Blonder Tongue Laboratories, Inc. issued
a press release announcing its financial results for the third quarter ended September 30, 2019. A copy of the press release is
attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference. The information disclosed
in this Current Report on Form 8-K, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934.
Item
9.01 Financial Statements and Exhibits
(d) Exhibits. The following
exhibit is filed herewith:
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
BLONDER TONGUE LABORATORIES, INC.
|
|
|
|
|
By:
|
/s/ Eric Skolnik
|
|
|
Eric Skolnik
|
|
|
Senior Vice President and
Chief Financial Officer
|
Date: November 6, 2019
EXHIBIT INDEX
3
Blonder Tongue Laborator... (AMEX:BDR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Blonder Tongue Laborator... (AMEX:BDR)
Historical Stock Chart
From Apr 2023 to Apr 2024